A major theme in constraint-based modeling is unifying experimental data, such as biochemical information about the reactions that can occur in a system or the composition and localization of enzyme complexes, with highthroughput data including expression data, metabolomics, or DNA sequencing. The desired result is to increase predictive capability resulting in improved understanding of metabolism. The approach typically employed when only gene (or protein) intensities are available is the creation of tissue-specific models, which reduces the available reactions in an organism model, and does not provide an objective function for the estimation of fluxes, which is an important limitation in many modeling applications. We develop a method, flux assignment with LAD (least absolute deviation) convex objectives and normalization (FALCON), that employs metabolic network reconstructions along with expression data to estimate fluxes. In order to use such a method, accurate measures of enzyme complex abundance are needed, so we first present a new algorithm that addresses quantification of complex abundance. Our extensions to prior techniques include the capability to work with large models and significantly improved run-time performance even for smaller models, an improved analysis of enzyme complex formation logic, the ability to handle very large enzyme complex rules that may incorporate multiple isoforms, and depending on the model constraints, either maintained or significantly improved correlation with experimentally measured fluxes. FALCON has been implemented in MATLAB and ATS, and can be downloaded from: https://github.com/bbarker/FALCON. ATS is not required to compile the software, as intermediate C source code is available, and binaries are provided for Linux x86-64 systems. FALCON requires use of the COBRA Toolbox, also implemented in MATLAB.
Introduction
FBA (flux balance analysis) is the oldest, simplest, and perhaps most widely used linear constraint-based metabolic modeling approach (Shestov et al., 2013; Lewis et al., 2012) . FBA has become extremely popular, in part, due to its simplicity in calculating reasonably accurate microbial fluxes or growth rates (e.g. Schuetz et al. 2012; Fong and Palsson 2004) ; for many microbes, a simple synthetic environment where all chemical species are known suffices to allow proliferation, giving fairly complete constraints on model inputs. Additionally, it has been found that their biological objectives can be largely expressed as linear objectives of fluxes, such as maximiztion of biomass (Schuetz et al., 2012) . Neither of these assumptions necessarily hold for mammalian cells growing in vitro or in vivo, and in particular the environment is far more complex for mammalian cell cultures, which have to undergo gradual metabolic adaptation via titration to grow on synthetic media (Pirkmajer and Chibalin, 2011) . Recently, there have been many efforts to incorporate both absolute and differential expression data into metabolic models (Blazier and Papin, 2012) . The minimization of metabolic adjustment (MoMA) algorithm is the simplest metabolic flux fitting algorithm, and it can be extended in order to allow the use of absolute expression data for the estimation of flux as in FALCON (Segrè et al., 2002; Lee et al., 2012) .
The MoMA method is framed as a constrained least-squares optimization problem, is typically employed to calculate the flux vector of an in silico organism after a mutation by minimizing the distance between the wild-type flux and the mutant flux. The biological intuition is that the organism has not had time to adapt to the restricted metabolic capacity and will maintain a similar flux to the wild-type (WT) except where the perturbations due to the mutation dictate necessary alterations in fluxes (Shlomi et al., 2005) . Suppose a is the WT flux vector obtained by an optimization procedure such as FBA, empirical measurements, or a combination of these. 
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T and S is the stoichiometric matrix (rows correspond to metabolites, columns to reactions, and entries to stoichiometric coefficients). Constant bounds on fluxes are often present, such as substrate uptake limits, or experimental V max estimates, so we write these as the constraints v lb v v ub . The objective may be equivalently expressed in the canonical quadratic programming (QP) vector form as min. T v − a T v. This assumes that each a i is measured, but it is also possible and sometimes even more useful to employ this objective when only a subset of the a i are measured (if a i is not measured for some i, then we omit (v i − a i ) 2 from the objective). In metabolomics, for instance, it is always the case in experiments with labeled isotope tracers that only a relatively small subset of all fluxes are able to be estimated with metabolic flux analysis (MFA; Shestov et al. 2013) . Combining MoMA with MFA provides a technique to potentially estimate other fluxes in the network.
A variant of MoMA exists that minimizes the absolute value of the difference between a i and v i for all known a i . To our knowledge, the following linear program is the simplest version of linear MoMA, which assumes the existence of a constant flux vector a:
The d i are just the distances from a priori fluxes to their corresponding fitted fluxes. Linear MoMA has the advantage that it is not biased towards penalizing large magnitude fluxes or under-penalizing fluxes that are less than one (Boyd and Vandenberghe, 2004; Shlomi et al., 2005) . Additionally, linear programs are often amenable to more alterations that maintain convexity than a quadratic program (Boyd and Vandenberghe, 2004) .
If we wish to apply MoMA to expression data rather than flux data, there are two primary problems that must be tackled. First, we must quantify enzyme complex abundance as accurately as possible given the gene expression data.
Although there is not a one-to-one correspondence between reactions and enzyme complexes, the correspondence is much closer than that between individual genes and metabolic reactions. In the first part of this work, we describe an algorithm that can account for enzyme complex formation and thus quantify enzyme complex abundance. Next, we build on the original MoMA objective, which must be altered in several ways (also discussed in Lee et al. 2012 which lays the groundwork for the current method). We automatically scale expression values so that they are comparable to flux units obtained in the optimization routine, which can be an advantage over the prior method as it requires the manual choice of a flux and complex abundance pair with ratio that is assumed to be representative of every reaction. Also, expression data has no directionality, necessitating reaction direction assignment in order to compare enzyme complex abundance and flux directly in the optimization problem (Lee et al., 2012) . Finally, we employ several sensitivity analyses and performance benchmarks so that users of the FALCON method and related methods may have a better understanding of what to expect in practice.
Methods
Most genome-scale models have attached Boolean (sans negation) gene rules to aid in determining whether or not a gene deletion will completely disable a reaction. These are typically called GPR (gene-protein-reaction) rules and are a requirement for FALCON; their validity, like the stoichiometric matrix, will undoubtedly be important for generating accurate predictions. Also important are the assumptions and limitations for the process of mapping expression data to complexes so that a scaled enzyme complex abundance (hereafter referred to as complex abundance) can be estimated. We address these in the next section and have attached a flow chart to illustrate the overall process of mapping expression of individual genes to enzyme complexes within the greater context of flux estimation (Fig. 1) . We develop an algorithm for this step-finding the minimum disjunction-for estimating complex abundance as efficiently and as accurately as possible given the assumptions (due primarily to limitations in data quality; Section 6).
Consideration of constraint availability is crucial in this type of analysis. In order to work with different constraint sets in yeast, we wrote the MATLAB function removeEnzymeIrrevs to find all enzymatic reactions in a model that are annotated as reversible but are constrained to operate in one direction only. The script then changes the bounds to allow flux in both directions. The function useYN5irrevs copies the irreversible annotations found in Yeast 5.21 (Lee et al., 2012) to a newer yeast model, but could in principle be used for any two models; by default, this script is coded to first call removeEnzymeIrrevs on both models before copying irreversible annotations. Application of these scripts removes 853 constraints in Yeast 5.21 and 1,723 constraints in Yeast 7. Despite the significant relaxation in constraints, since nutrient uptake constraints are unaffected, FBA only predicts a 1.28% increase in growth rate in the minimally constrained Yeast 7 model. However, in FALCON, we are no longer optimizing a sink reaction like biomass, and this relaxation in internal constraints proves to be more important. Constraint sets for Human Recon 2 are described in Fig. 8. 
Estimating enzyme complex abundance
Given the diversity and availability of genome-scale expression datasets, either as microarray or more recently RNASeq, it could be useful to gauge the number of enzyme complexes present in a cell. A recent study found that only 11% of annotated Drosophila protein complexes have subunits that are co-expressed (Jüschke et al., 2013) , so it cannot be assumed that any given protein subunit level represents the actual complex abundance. We formalize a model for enzyme complex formation based on GPR rules that are frequently available in genome-scale annotations.
The original expression to complex abundance mapping procedure performed a direct evaluation of GPR rule expression values-replacing gene names with their expression values, ANDs with minimums, and ORs with sums, without altering the logical expression of the GPR rule in any way (Lee et al., 2012) . Below we illustrate a problem that can occur with this mapping where some genes' expression levels may be counted more than once.
The r i are different reaction rules and the e i are the corresponding estimated complex abundance levels. Lower case letters are shorthand for the expression level of the corresponding gene ID in uppercase; for example, a = E (A), where E (A) is the expression of gene A. Figure 1: Flowchart illustrating the two algorithms presented in this paper. The process of estimating enzyme complex abundance is displayed in detail, whereas the flux-fitting algorithm (FALCON) is illustrated as a single step for simplicity. First, for each gene in the model with available expression data, the mean and (if available) standard deviation or some other measure of uncertainty are read in. Gene rules (also called GPR rules) are also read in for each enzymatic reaction. The reaction rules are parsed and the minimum disjunction algorithm (Algorithm 7.1) is applied, making use of the gene's mean expression. Next, the estimated and unitless enzyme complex abundance and variance are output for each enzymatic reaction. Finally, flux fitting with FALCON (Algorithm 8.1) can be applied, and requires the model's stoichiometry and flux bounds. The final output has the option of being a deterministically estimated flux, or a mean and standard deviation of fluxes if alternative optima are explored.
Supposing A is the minimum, then if we just evaluate r 1 directly (a rule in disjunctive normal form, or DNF), A will be counted twice. Rules with sub-expressions in DNF are frequently encountered in practice, but directly evaluating them can lead to erroneous quantification.
Another possibility is partitioning expression among multiple occurrences of a gene in a rule. For instance, in r 1 above, we could evaluate it as e 1 = min( a 2 , b) + min( a 2 , c) to account for the repeated use of a. However, other potential issues aside, we can see that this can cause problems rather quickly. For instance, suppose b = a and c = 0; then min(a,b + c) = b = a appears to be correct, not min(
From this example, we can see that conversion to conjunctive normal form (CNF), as in r 2 appears to be a promising prerequisite for evaluation.
The min-disjunction algorithm estimates enzyme complex abundance
In Section 6, we show that converting a rule to CNF is a sound method to aid in the estimation of enzyme complex abundance. We use a reduction rule that removes redundant genes from the complex (e.g. holoenzymes; see Assumption 8), outlined below. This effectively finds the rate-limiting component of enzyme-complex formation (Algorithm 7.1).
Although conversion to CNF may be intractable for some rules (Russell and Norvig, 2009) , we tested our implementation of the algorithm on three of the most well-curated models which likely contain some of the most complex gene rules available. These models are for E. coli (Orth et al., 2011) , yeast (Aung et al., 2013) , and human (Thiele et al., 2013) . In all cases, the rules were converted to CNF in less than half a second, which is far less than the typical flux fitting running time from Algorithm 8.1. We also present a heuristic algorithm (Section 7.2) that should work quickly even on rules that are not able to be strictly converted to CNF, and in most cases should still yield the minimum disjunction.
Application of Algorithm 7.1 results in several differences from direct substitution and evaluation in yeast GPR rules. When data completely covers the genes in the model (e.g. Lee et al. 2012) , complex abundance tends to have few differences in yeast regardless of the evaluation method (25 rules; 1.08% of all rules for Yeast 7). This number goes up significantly in Human Recon 2 (Thiele et al., 2013) due to more complex GPR rues (935 rules; 22% of all rules). For the human model, we could not find any data set that covered every gene, so instead random expression data roughly matching a power law was used to generate this statistic. If we use proteomics data for yeast and human models, the algorithmic variation in how missing gene data is handled causes some additional increase in differences (Picotti et al., 2013; Gholami et al., 2013) . For proteomics, in the Yeast 7 model 205 rules (8.87% of all rules) differed, and in Human Recon 2, 1002 rules (23.57% of all rules) differed. We can see that for yeast, the changes in flux attributed to enzyme abundance evaluation can be relatively small for data with 100% gene coverage, but can be significant in Human (Fig. 5 ).
Formulation with automatic normalization and batch direction assignment
Prior work that served as an inspiration for this method used Flux Variability Analysis (FVA) to determine reaction direction (Lee et al., 2012) . Briefly, this involves two FBA simulations per reaction catalyzed by an enzyme, and as the algorithm is iterative, this global procedure may be run several times before converging to a flux vector. We removed FVA to mitigate some of the cost, and instead assign flux direction in batch; while it is possible that the objective value may decrease using this approach, this is not an issue since the objective function increases to include more irreversible fluxes at each iteration, and the objective value of a function with more fluxes should supersede the importance of one with fewer fluxes.
One major improvement in our method is the consideration of enzyme complexes sharing multiple reactions, which we call reaction groups. This is done by partitioning an enzyme complex's abundance across its reactions by including all reactions associated to the complex in the same constraint. Both minimally and highly constrained models (Section 3.2) show some fluxes with significant differences depending on the use of group information, particularly in the minimally constrained model (Fig. 2) . Several other features of the algorithm, including automatic scaling of expression, are discussed in Section 8.
Algorithm 8.1 and the method in Lee et al. 2012 are both non-deterministic. In the first case, Algorithm 8.1 solves an LP during each iteration, and subsequent iterations depend on the LP solution, so that alternative optima may affect the outcome. In the latter case, alternative optima of individual LPs is not an issue, but the order in which reactions assigned to be irreversible can lead to alternative solutions. However, we found that the variation due to this stochasticity is typically relatively minor, particularly in cases where the model is more heavily constrained (Figs. 5 and 6).
Results and Discussion

Performance benchmarks
Using the same yeast exometabolic and expression data employed for benchmarking in the antecedent study (Lee et al., 2012) that included an updated version of the Yeast 5 model (Heavner et al., 2012) and the latest yeast model (Aung et al., 2013) , we find that our algorithm has significant improvements in time efficiency while maintaining correlation with experimental fluxes, and is much faster than any similarly performing method (Table 1 ; Fig. 6 ). Timing for the human model also improved in FALCON; in a model with medium constraints and exometabolic directionality constraints, FALCON completed on average in 3.6 m and the method from Lee et al. 2012 in 1.04 h. Furthermore, when we remove many bounds constraining the direction of enzymatic reactions that aren't explicitly annotated as being irreversible in prior work (Lee et al., 2012) , we find that our formulation of the approach seems to be more robust than other methods. We see that the predictive ability of the algorithm does not appear to be an artifact; when FALCON is run on permuted expression data, it doesn't do as well as the actual expression vector (Fig. 3) . The full-sized flux vectors estimated from permuted expression as a whole also does not correlate well with the flux vector estimated from the actual expression data, but we notice that the difference is visibly larger in the minimally constrained model compared to the highly constrained model (Fig. 7) . Rigidity in the highly constrained model appears to keep most permutations from achieving an extremely low Pearson correlation, likely due to forcing fluxes through the same major pathways, but a rank-based correlation still shows strong differences. 
Sensitivity to expression noise
To understand the sensitivity of flux to expression, we multiply noise from multivariate log-normal distributions with the expression vector and see the effect on the estimated fluxes. For instance, correlation between two types of proteomics data yields a Pearson's r = 0.7 (Gholami et al., 2013) , corresponding to an expected σ ≈ 1.4 and expected r ≈ 0.4 for flux in our most highly constrained human model (Fig. 8 ). We find that enzymatic reaction directionality constraints influence the sensitivity of the model to expression perturbation (Fig. 4) . It is important to note that mere presence of the constraints does not help us determine the correct experimental fluxes when other classes of methods (e.g. FBA; Table 1 ) are used. Additionally, it is possible to obtain good predictions even without a heavily constrained model (Table 1) . With Human Recon 2, additional constraint sets supply some benefit, but even the most extreme constraint set does not compare to what is available in Yeast 7, which is also inherently constrained by the fact that yeast models will be smaller than comparable human models (Fig. 8) . For mammalian models, more sophisticated means of constraint, such as enzyme crowding constraints (Shlomi et al., 2011) , or using FALCON in conjunction with tissue specific modeling tools, may prove highly beneficial.
Flux estimates provides information beyond enzyme complex abundance
It is not an unreasonable hypothesis that fluxes would correlate well with their associated complex abundances. Indeed, the general principle needed for fitting fluxes to enzyme complex abundances is to assume the values would be correlated in the absence of other constraints (e.g. branch points that arise from the stoichiometry). More specifically, it should be the case that flux is proportional to enzyme complex abundance given ample availability of substrate, and that this proportionality constant does not vary too much between reactions. There are undoubtedly many exceptions to this rule, but it seems as though there may be some underlying evolutionary principles for it to work in this parsimonious fashion, as has been partly verified (Bennett et al., 2009) .
Aside from the obvious benefits of constraint-based methods also estimating fluxes for non-enzymatic reactions, and assigning a direction for reversible enzymatic reactions, we see that in general, our method does not predict a strong correlation between complex abundance and flux (Fig. 9) . Recently it has been shown that many fluxes are not under direct control of their associated enzyme expression level (Chubukov et al., 2013) , which gives experimental support to the idea that a network-based approach, such as that presented in this paper, may be useful in understanding how fluxes may be constrained by expression data. Chubukov et al. 2013 also note that enzymes may be overexpressed in some cases, either for robustness or because of noise in transcriptional regulation. This will not usually be a problem in FALCON, unless entire pathways are overexpressed, which would be unusual as it would represent a seemingly large energetic inefficiency.
The present work doesn't attempt to use empirically obtained kinetic parameters to estimate V max , but this approach does not seem as promising in light of experimental evidence that many reactions in central carbon metabolism tend to operate well below V max (Bennett et al., 2009) . Still, a better understanding of these phenomena may make it possible to improve flux estimation methods such as the one presented here, or more traditional forms of MFA (Shestov et al., 2013) by incorporating enzyme complexation and kinetic information.
Increasing roles for GPR rules and complex abundance estimates
Still, complex abundance may have uses aside from being a first step in FALCON. The method presented here for complex abundance estimation can be used as a stand-alone method, as long as GPR rules from a metabolic reconstruction are present. For instance, it may not always be desirable to directly compute a flux. As an example, the relative abundance of enzyme complexes present in secretions from various biological tissues, such as milk or pancreatic secretions, may still be of interest even without any intracellular flux data. Perhaps more importantly, this approach to estimating relative complex levels can be employed with regulatory models such as PROM (Chandrasekaran and Price, 2010) or other regulatory network models that can estimate individual gene expression levels at time t + 1 given the state of the model at a time t.
GPR rules and stoichiometry may be inaccurate or incomplete in any given model. In fact, for the foreseeable future, this is a given. By using the GPR and not just the stoichiometry to estimate flux, it is possible that future work could make use of this framework to debug not just stoichiometry as some methods currently do (e.g. Reed et al. 2006) , but also GPR rules. Hope for improved GPR rule annotation may come from many different avenues of current research. For instance, algorithms exist for reconstructing biological process information from large-scale datasets, and could be tuned to aid in the annotation of GPR rules (Mitra et al., 2013) . Flexible metabolic reconstruction pipelines such as GLOBUS may also be extended to incorporate GPR rules into their output, and in so doing, extend this type of modeling to many non-model organisms (Plata et al., 2012) . Another limitation that relates to lack of biological information is that we always assume a one-to-one copy number for each gene in a complex. Once more information on enzyme complex structure and reaction mechanism becomes available, an extension to the current method could make use of this information. Even at the current level of structure, we think it is evident that GPR rules should ungergo some form of standardization; Boolean rules without negation may not always capture the author's intent for more complex purposes like flux fitting.
Conclusion
We have formalized and improved an existing method for estimating flux from expression data, as well as listing detailed assumptions in Table 2 that may prove useful in future work. Although we show that expression does not correlate well with flux, we are still essentially trying to fit fluxes to expression levels. The number of constraints present in metabolic models (even the minimally constrained models) prevents a good correlation between the two. However, as with all constraint-based models, constraints are only part of the problem in any largely underdetermined system. We show that gene expression can prove to be a valuable basis for forming an objective, as opposed to methods that only use expression to further constrain the model by creating tissue-specific or condition-specific models (Shlomi et al., 2008; Becker and Palsson, 2008) .
For better curated models, the approach described immediately finds use for understanding metabolism, as well as being a scaffold to find problems for existing GPR rules, and more broadly the GPR formalism itself. The present results and avenues for future improvement show that there is much promise for using expression to estimate fluxes, and that it can already be a useful tool for performing flux estimation and analysis. and the minimum disjunction algorithm (y-axis); error bars with length equal to one standard deviation are shown for both approaches as a result of alternative solutions in FALCON. Yeast was evaluated with default (highly) constrained (a) and minimally constrained (b) models, and no strong difference between direct evaluation or or the minimum disjunction method is observed in either case. However, for human models with a highly constrained reaction set (RPMI media, CORE-sign, and enzymatic direction) (c) and default constraints (d), we see there is a large amount of variation between the two evaluation techniques. In the human cases, two outliers were not shown that correspond to a single large flux cycle ('release of B12 by simple diffusion' and 'transport of Adenosylcobalamin into the intestine'). We used several different constraint sets based on experimental media and exometabolic flux data in the NCI-60 cell lines (Jain et al., 2012) . These constraints were applied cumulatively, and are listed in the order of most constrained (b) to least constrained (f). Included are default Recon 2 constraints (f), RPMI media constraints (e; function constrainCoReMinMaxSign; 556 constraints), exometabolic fluxes with a common sign across all cell lines and replicates (d; function constrainCoReMinMaxSign; 567 cumulative constraints), enzymatic reaction directionality constraints from a linear MoMA fitting on the exometabolic flux data that agree across all NCI-60 cell lines (c; constrainImputedInternal; 593 cumulative constraints), and the same again considering all reactions instead of only enzymatic reactions (b; 618 cumulative constraints). , the upper and lower triangles are the 75% and 85% maximum growth conditions, respectively, and human is done similarly with the K562 and MDA-MB-231 cell lines (b). As for expression estimates, the sum of expression and enzyme complex estimate levels are generally the least correlated with other expression estimates. As expected, the enzyme complex estimates are the most correlated with the FALCON fluxes, as they are used in the algorithm. However, it is important to note that they are not very similar, exemplifying the affect the network constraints play when determining flux. Interestingly, enzyme complex abundance is found to correlate very highly with the maximum expression level for the complex; this can be attributed to many genes having relatively simple complexes that are isozymes, where one major isozyme is typically highly expressed.
Assumptions for enzyme complex formation
In order to quantify enzyme complex formation (sometimes called enzyme complexation), the notion of an enzyme complex should be formalized. A protein complex typically refers to two or more physically associated polypeptide chains, which is sometimes called a quaternary structure. Since we are not exclusively dealing with multiprotein complexes, we refer to an enzyme complex as being one or more polypeptide chains that act together to carry out metabolic catalysis. Assumption 1. A fundamental assumption that we need in order to guarantee an accurate estimate of (unitless) enzyme complex abundance are the availability of accurate measurements of their component subunits. Unfortunately, this is currently not possible, and we almost always must make do with mRNA measurements, which may even have some degree of inaccuracy in measuring the mRNA abundance. What has been seen is that Spearman's ρ = 0.6 for correlation between RNA-Seq and protein intensity in datasets from HeLa cells (Nagaraj et al., 2011) . This implies that much can likely still be gleamed from analyzing RNA-Seq data, but, an appropriate degree of caution must be used in interpreting results based on RNA-Seq data. By incorporating more information, such as metabolic constraints, we hope to obviate some of the error in estimating protein intensity from RNA-Seq data.
Assumption 2. We also include the notion of isozymes-different proteins that catalyze the same reaction-in our notion of enzyme complex. Isozymes may arise by having one or more differing protein isoforms, and even though these isoforms may not be present in the same complex at the same moment, we consider them to be part of the enzyme complex since one could be substituted for the other. Gibbons et al. 2000; Bernstein et al. 1978; Gezelter et al. 2013) . This illustration demonstrates both how an enzyme complex may be constituted by multiple subunits (left), and how some of those subunits may be products of the same gene and have differing stoichiometries within the complex (right).
As an example for assumptions described so far, take the F 1 subcomplex of ATP Synthase (Fig. 10) , which is composed of seven protein subunits (distinguished by color, left). On the right-hand side we see different isoforms depicted as different colors. Error in expression data aside, instead of considering the abundances with multiplicity and dividing their expression values by their multiplicity, it may be easier to simply note that the axle peptide (shown in red in the center of the complex) only has one copy in the complex, so its expression should be an overall good estimation of the F 1 subcomplex abundance. This reasoning will be useful later in considering why GPR rules may be largely adequate for estimating the abundance of most enzyme complexes.
Assumption 3. The modeling of enzyme complex abundance can be tackled by using nested sets of subcomplexes; each enzyme complex consists of multiple subcomplexes, unless it is only a single protein or family of protein isozymes. These subcomplexes are required for the enzyme complex to function (AND relationships), and can be thought of as the division of the complex in to distinct units that each have some necessary function for the complex, with the exception that we do not keep track of the multiplicity of subcomplexes within a complex since this information is, in the current state of affairs, not always known. However, there may be alternative versions of each functional set (given by OR relationships). Eventually, this nested embedding terminates with a single protein or set of peptide isoforms (e.g. isozymes). In the case of ATP Synthase, one of its functional sets is represented by the F 1 subcomplex. The F 1 subcomplex itself can be viewed as having two immediate subcomplexes: the single γ (axle) subunit and three identical subcomplexes each made of an α and β subunit. Each αβ pair works together to bind ADP and catalyze the reaction (Oster and Wang, 2003 ). The αβ subcomplex itself then has two subcomplexes composed of just an α subunit on the one hand and the β subunit on the other. It is obvious that one of these base-level functional subcomplexes (in this example, either γ or αβ) will be in most limited supply, and that it will best represent the overall enzyme complex abundance (discounting the issues of multiplicity for αβ, discussed above).
The hierarchical structure just described, when written out in Boolean, will give a rule in CNF (conjunctive normal form), or more specifically (owing to the lack of negations), clausal normal form, where a clause is a disjunction of literals (genes). This is because all relations are ANDs (conjunctions), except possibly at the inner-most subcomplexes that have alternative isoforms, which are expressed as ORs (disjunctions). Since GPR rules alone only specify the requirements for enzyme complex formation, we will see that not all forms of Boolean rules are equally useful in evaluating the enzyme complex abundance, but we have established the assumptions in Table 2 and an alternative and logically equivalent rule (Russell and Norvig, 2009 ) under which we can estimate enzyme complex copy number.
There is no guarantee that a GPR rule has been written down with this hierarchical structure in mind, though it is likely the case much of the time as it is a natural way to model complexes. However, any GPR rule can be interpreted in the context of this hierarchical view due to the existence of a logically equivalent CNF rule for any non-CNF rule, 2. Protein isoforms contributing to isozymes are considered part of the same enzyme complex.
3. Any enzyme complex can be described as a hierarchical subset of (possibly redundant) subcomplexes; redundant subcomplexes, as elaborated in (4), are not currently modeled.
4. Assume one copy of peptide per complex; exact isoform stoichiometry is not considered.
5. With the exception of complexes having identical rules (i.e. the same complex listed for different reactions), each copy of a peptide is available for all complexes in the model.
6. There is only one active site per enzyme complex.
7. We assume that different pathways have similar flux sensitivities with respect to their enzyme abundances.
8. If a particular subcomplex can be catalyzed by A and it can also be catalyzed by A and B (e.g. B acts as a regulatory unit, as in holoenzymes), this just simplifies to A once expression values are substituted in. Similarly, allosteric regulation is not modeled. Relatedly, there are no NOT operations in GPR rules (just ANDs and ORs).
9. Enzyme complexes form without the assistance of protein chaperones and formation is not coupled to other reactions.
10. Rate of formation and degradation of complexes doesn't play a role, since we assume steady-state. and it is obvious that logical equivalence is all that is required to check for enzyme complex formation when exact isoform stoichiometry is unknown. As an example, we consider another common formulation for GPR rules, and a way to think about enzyme structure-disjunctive normal form (DNF). A DNF rule is a disjunctive list of conjunctions of peptide isoforms, where each conjunction is some variation of the enzyme complex due to substituting in different isoforms for some of the required subunits. A rule with a more complicated structure and compatible isoforms across subcomplexes may be written more succinctly in CNF, whereas a rule with only very few alternatives derived from isoform variants may be represented clearly with DNF. In rare cases, it is possible that a GPR rule is written in neither DNF or CNF, perhaps because neither of these two alternatives above are strictly the case, and some other rule is more succinct. Assumptions 4, 5 and 6. One active site per enzyme complex implies a single complex can only catalyze one reaction at a time. Multimeric complexes with one active site per identical subunit would be considered as one enzyme complex per subunit in this model. Note that it is possible for an enzyme complex to catalyze different reactions. In fact, some transporter complexes can transfer many different metabolites across a lipid bilayer-up to 294 distinct reactions in the reversible model for solute carrier family 7 (Gene ID 9057). Another example is the ligation or hydrolysis of nucleotide, fatty acid, or peptide chains, where chains of different length may all be substrates or products of the same enzyme complex. While we do not explicitly consider these in Algorithm 7.1, these redundancies are taken into account subsequently in Algorithm 8.1.
What is currently not considered in our process is that some peptide isoforms may find use in completely different complexes, and in some cases, individual peptides may have multiple active sites; in the first case, we assume an unrealistic case of superposition where the isoform can simultaneously function in more than one complex. The primary reason we have not tackled this problem is because exact subunit stoichiometry of most enzyme complexes is not accurately known, but an increasing abundance of data on BRENDA (Schomburg et al., 2013) gives some hope to this problem. A recent E. coli metabolic model incorporating the metabolism of all known gene products (O'Brien et al., 2013 ) also includes putative enzyme complex stoichiometry in GPR rules. For the second point, there are a few enzymes where a single polypeptide may have multiple active sites (e.g. fatty acid synthase), and this is not currently taken into account in our model. Assumption 8. We do not make any special assumptions requiring symmetry of an isoform within a complex. For instance, the example in assumption 8 shows how you might have one subcomponent composed of a single isoform, and another subcomponent composed of that gene in addition to another isoform. In this case, it is simply reduced to being the first gene only that is required, since clearly the second is strictly optional. That isn't to say that the second gene may not have some effect, such as (potentially) aiding in structural ability or altering the catalytic rate, but it should have no bearing on the formation of a functional catalytic complex. Holoenzymes-enzymes with metabolic cofactors or protein subunits that have a regulatory function for the complex-would likely be the only situation where this type of rule might need to be considered in more detail. But in the absence of detailed kinetic information, this consideration (much like allosteric regulation) is not useful.
Assumption 7. Another important biochemical assumption is that reactions should operate in a regime where they are sensitive to changes in the overall enzyme level in the pathways that they belong in (Bennett et al., 2009; Chubukov et al., 2013) . This is perhaps the most important issue to be explored further for methods like this, since if it is not true, some other adjustment factor would be needed to make the method realistic. For instance, if all reactions in a pathway are operating far below V max , but it is not the case in another pathway, the current method does not have information on this, and will try to put more flux through the first pathway than should be the case.
Assumptions 9 and 10. Due to the quickness, stability, and energetic favorability of enzyme complex formation, the absence of chaperones or coupled metabolic reactions required for complex formation may be reasonable assumptions, but further research is warranted (Karr et al., 2012) . Additionally, as in metabolism, we assume a steady state for complex formation, so that rate laws regarding complex formation aren't needed. However, further research may be warranted to investigate the use of a penalty for complex levels based on mass action and protein-docking information. Requisite to this would be addressing assumption 4. It would be surprising (but not impossible) if such a penalty were very large due to the cost this would imply for many of the large and important enzyme complexes present in all organisms (Nelson and Cox, 2008) .
Algorithms for finding the minimum disjunction
Below we discuss both the exact (conjunctive normal form) method for finding enzyme abundance that we have implemented, and a heuristic that is not implemented but could be useful for gene rules that are more complex than any currently existing rules. Create G 1 and G 2 with g 1,i ∈ G 1 and g 2,i ∈ G 2 where 
The
x d = (g 1,1 ∧ . . . ∧ g 1,r ) ∨ (g 2,1 ∧ . . . ∧ g 2,s ). if G 1 ⊆ G 2 then Replace x d with (g 1,1 ∧ . . . ∧ g 1,r ). else if G 2 ⊆ G 1 then Replace x d with (g 2,1 ∧ . . . ∧ g 2,s ). end if end if Distribute ∨ over ∧, e.g.: (x 1 ∧ x 2 ) ∨ (x 3 ∧ x 4 ) → (x 1 ∨ x 3 ) ∧ (x 1 ∨ x 4 ) ∧ (x 2 ∨ x 3 ) ∧ (x 2 ∨ x 4 ) end
The min-disjunction heuristic algorithm
Because conversion to CNF is potentially computationally intractable for some rules due to an exponential increase in memory (Russell and Norvig, 2009 ), we present below a reduction rule that makes use of expression data. The algorithm can be described as follows: Create G 1 and G 2 with g 1,i ∈ G 1 and g 2,i ∈ G 2 where
Substitute x d with: The intuition for this algorithm is that it returns the minimum disjunction because at each iteration; we select the literal with smallest value in a conjunction and remove all other literals in the conjunction. Distributing ∨ over ∧ and subsequently evaluating the associated expression values will not change which disjunction attains the minimum value.
While this algorithm should work in most cases just as the algorithm in Section 7.1, there is a notable exception that can occur when one or more genes appear in two conjunctions; this possibility is handled in the conditional by treating the intersection of the gene sets G C separately. Unfortunately, this step is not associative over disjunctions, so if there are more than two disjunctions at the same level, it is not guaranteed to be accurate.
While this algorithm is not currently implemented exactly as stated, an earlier version of this algorithm was implemented in ATS1, and is available in the deprecated file minDisjNoCov.dats. The algorithm can be implemented without much troubled based on the existing code in the FALCON software package.
Proof for the minDisjunction heuristic algorithm
Although the intuition presented above may be straightforward, we show here in more verbosity that Algorithm 7.2 works as described.
Theorem 1. Algorithm 7.2 returns the disjunction with minimum expression value among all disjunctions of a rule in CNF.
Proof. Due to our Boolean algebra currently lacking negation, the only step in converting to CNF that we need is the distributive expansion of ∧ over ∨. However, in order to allow M to be applied to conjunctive sets that are in disjunction with one another, we must ensure that the sets are disjoint, which is taken care of first in the algorithm by handling the intersection of the conjunctive sets, G C = G 1 ∩ G 2 , separately. In practice, if G 1\C = ∅ or G 2\C = ∅, then this means we have a situation similar to that described in assumption 8, and the entire expression is simplified to ∧ g c ∈G C g c . Otherwise, a direct route is taken to compute distributive law for the literals:
we show that by applying M to G 1\C and G 2\C , we can compute the correct minimum disjunction without the need to compute and store in memory every disjunction in the expansion, which results in the following:
Now let us consider when expressions x 1 , ..., x 4 are all distinct literals, and that E (x i ) denotes the enzyme abundance for expression x i (or the expression measure of x i if x i is a gene). Assume WLOG that x 1 ∨ x 3 attains the minimum expression among the disjunctions. Then we have:
Applying this result in conjunction to the application of M to the original expression, (x 1 ∧ x 2 ) ∨ (x 3 ∧ x 4 ), we immediately arrive at (x 1 )∨(x 3 ), which gives our originally assumed minimum. To show that this result doesn't depend on the x i being literals, merely consider repeating this process recursively for each x i that is not a literal to arrive at two different evaluations for E (x i ) (one where each evaluation is done with reduction, and one where we evaluate entirely without reduction). Since the process cannot continue indefinitely, eventually there is a base case involving only literals, and the above result shows that, at each step, as we backtrack from the base case, both evaluations will be identical. The desired result is obtained because Algorithm 7.2 without the conditional simply yields CNF, and it follows that adding the conditional will yield the disjunction with minimum expression value of the rule in CNF.
The FALCON algorithm
To make working with irreversible fluxes simpler, we convert the model to an irreversible model, where each reversible flux v j in the original model is split into a forward and a backward reaction that take strictly positive values: v j, f and v j,b . If v j is specified without a forward or backward subscript and it is in the context of an irreversible model, this implies that the reaction direction is irreversible. We also account for enzyme complexes catalyzing multiple reactions by including all reactions with identical GPR rules in the same residual constraint; indexed sets of reactions are denoted R i and their corresponding estimated enzyme abundance is e i . Fig. 2 shows the difference in Algorithm 8.1 when we do not use reaction group information. Note that we use a slight abuse of notation, since we also choose to index enzyme abundance as e j for a specific reaction, where j = i does not imply e i = e j . The existence of e j merely means that some expression data is available for some of the genes for e j ; missing genes are removed from the rule during the call to min-disjunction-values known to be zero can always be specified as such. The standard deviation of enzyme abundance, σ i , is an optional weighting of uncertainty in biological or technical replicates.
We employ a normalization variable n in the problem's objective and flux-fitting constraints to find the most agreeable scaling of expression data. The linear fractional program shown below can be converted to a linear program by the Charnes-Cooper transformation (Boyd and Vandenberghe, 2004) . To avoid the need for fixing any specific flux, which may introduce bias, we introduce the bound j|e j exists v j ≥ V Σ lb . This guarantees that the optimization problem will yield a non-zero flux vector. As an example of how this can be beneficial, this means we do not need to measure any fluxes or assume a flux is fixed to achieve good results; though this does not downplay the value of obtaining experimentally-based constraints on flux when available (Fig. 6) .
The actual value of V Σ lb is not very important due to the scaling introduced by n, and we include a conservatively small value that should work with any reasonable model. However, for numeric reasons, it may be best if a user chooses to specify a value appropriate for the model. Similarly, if any fluxes are known or assumed to be non-zero, this constraint becomes unnecessary. To keep track of how many reactions are irreversible in the current and prior iteration, we use the variables rxns irrev and rxns irrev,prior . The algorithm terminates when no reactions are constrained to be exclusively forward or backward after an iteration. 
Constrain the smaller of v j, f and v j,b to be 0. rxns irrev ++ end for end while
Benchmarking of solvers
We have exclusively used the Gurobi solver (Gurobi Optimization, 2013) for this work, which is a highly competitive solver that employs by default a parallel strategy to solving problems: a different algorithm is run simultaneously, and as soon as one algorithm finished the others terminate. Of course, if there is a clear choice of algorithm for a particular problem class, this should be used in production settings to avoid wasted CPU time and memory. In order to address this, we benchmarked the three non-parallel solver methods in Gurobi (since parallel solvers simply use multiple methods simultaneously). The exception to this rule is the Barrier method, which can use multiple threads, but in practice for our models appears to use no more than about 6 full CPU cores simultaneously for our models. Our results for Yeast 5 and Yeast 7 with minimal directionality constraints (Heavner et al., 2012; Lee et al., 2012; Aung et al., 2013) and Human Recon 2 (Thiele et al., 2013) are shown in Table 3 ).
We found that in Yeast 7 with the primal-simplex solver, there is a chance the solver will fail to find a feasible solution. We verified that this is a numeric issue in Gurobi and can be fixed by setting the Gurobi parameter MarkowitzTol to a larger value (which decreases time-efficiency but limits the numerical error in the simplex algorithm). In practice, Table 4 : Running time per FALCON iteration (in seconds, ± standard deviation) using various algorithms implemented in the Gurobi package. For yeast models, 1,000 replicates were performed, and for the human model, 100 replicates were performed.
failure for the algorithm to converge at an advanced iteration is rare and is not always a major problem (since the previous flux estimate by the advanced iteration should already be quite good), but it is certainly undesirable; a warning message will be printed by falcon if this occurs, at which point parameter settings can be investigated. In the future, we plan to improve falcon so that parameters will be adjusted as needed during progression of the algorithm after finding a good test suite of models and data. For now, we use the dual-simplex solver, for which we have always had good results. Because the number of iterations depends non-trivially on the model and the expression data, it may be more helpful to look at the average time per iteration in the above examples (Table 4) . Given the above rare trouble with primal simplex solver the universal best performance enjoyed by the dualsimplex method (Tables 3 and 4) , we would advise the dual-simplex algorithms, all else being equal. The dual-simplex method is also recommended for memory-efficiency by Gurobi documentation, but we did not observe any differences in memory for different solver methods.
All timing analyses were performed on a system with four 8-core AMD Opteron™ 6136 processors operating at 2.4 GHz. Fig. 6 , Table 1, and Tables 3 and 4 used a single unperturbed expression file per species (S. cerevisiae and H. sapiens; see timingAnalysis.m for details). Values were averaged across 32 replicates. Note that the iMAT method is formulated as a mixed integer program (Shlomi et al., 2008) , and was able to use additional parallelization of the solver (Gurobi Optimization, 2013) whereas other methods only used a single core (our system had 32 cores and iMAT with Gurobi would use all of them). Tables 3 and 4 used multivariate log-normal noise multiplied by the original expression vector to introduce more variance in the calculations; the human models were tested with 100 replicates and the yeast models with 500 replicates.
Generation of figures and tables
All non-trivial figures can be generated using MATLAB scripts found in the analysis/figures subdirectory of the FALCON installation. In particular, figures should be generated through the master script makeMethodFigures.m by calling makeMethodFigures(figName) where figName has a name corresponding to the desired figure. In some cases, some MATLAB .mat files will need to be generated by other scripts first; see the plotting scripts or the subsections below for details. An example is to make the scatter plots showing the difference between running falcon with enzyme abundances determined by direct evaluation or the minimum disjunction algorithm; all three scatter plots are generated with the command makeMethodFigures('fluxCmpScatter'). Note that, as written, this requires a graphical MATLAB session.
Comparison of the effects of the employed enzyme complexation methods were evaluated using compareEnzymeExpression.m and compareFluxByRGroup.m. Comparison of reacion groups was performed in compareFluxByRGroup.m.
Timing analyses
All timing analyses were performed on a system with four 8-core AMD Opteron™ 6136 processors operating at 2.4 GHz. Fig. 6 and Table 1 used unperturbed expression data; see yeastResults.m for details). Values for the FALCON method were averaged across 32 replicates, while values for the Lee et al. 2012 method were averaged across 8 replicates. Human timing analyses were performed using methodTimer.m with 8 replicates.
Data sources
Enzyme complexation comparisons were performed on proteomics data from Gholami et al. 2013 (Human; 786-O cell line) and Picotti et al. 2013 (yeast; BY strain) , and on RNA-Seq data from Lee et al. 2012 (yeast; 75% max µ condition) .
